According to a new report published by Allied Market Research, titled, "Womens Health Diagnostics Market," The womens health diagnostics market size was valued at $19.2 billion in 2020, and is estimated to reach $36.3 billion by 2030, growing at a CAGR of 6.9% from 2021 to 2030.
Women's health diagnostics system improves the women's health by screening, diagnosing, and monitoring the disease conditions, such as different types of cancer, infertility, and other diseases. The cervical cancer screening supports infertility, prenatal testing, and pregnancy care to breast and ovarian cancer diagnosis to managing bone health & diagnostics. Increase in need for the diagnostics of women's health-related diseases is considered to be more susceptible to certain disorders, such as osteoporosis, menstrual disorders, cancer, and autoimmune diseases. The major diseases include, menopause, infertility, polycystic ovarian syndrome, and certain cancers, such as breast cancer and cervical cancer, as well as urological disorders. The medical diagnostics devices and tests help to improve the women's health and accurate treatment against disease
Do Enquiry for Sample Report @ https://www.alliedmarketresearch.com/request-sample/4521
By type, the market is divided into diagnostic devices, diagnostic tests, and accessories and consumables. The diagnostic tests segment was the highest contributor to the market in 2020. Increase in prevalence of various health-related disorders among women, such as cancer and infertility, growth in awareness about women's health-related tests, high demand for point-of-care diagnostic testing, and development of numerous diagnostic & imaging centers drive the women's health diagnostics market for tests.
By end user, the market is categorized into hospitals and clinics, home care settings, diagnostic & imaging centers, and others. The hospitals and clinics segment was the highest contributor to the market in 2020. The increase in incidence of breast and ovarian cancer has led to a significant rise in the number of hospitalization.
By region, North America constituted the highest womens health diagnostics market share in 2020, owing to numerous technological developments related to diagnosis of women and imaging techniques in this region. Asia-Pacific is projected to grow at the highest CAGR during the womens health diagnostics market forecast, owing to entry of novel tests and kits in the market, and rise in awareness about women's health diagnostics technology.
Key Market Segments
By Type
Accessories and Consumables
Diagnostic Tests
Breast Cancer Testing
Hormone Receptor Test
Immunohistochemistry (IHC) Test
Other Tests
Cervical Cancer Testing
PAP Smear (PAP) Test
HPV Test
Prenatal Genetic Screening and Carrier Testing
Cystic Fibrosis
Other Diseases
Pregnancy and ovulation testing
Lab based pregnancy and ovulation testing
Home based pregnancy and ovulation testing
Ovarian cancer testing
Key Market Players
ABBOTT LABORATORIES
BECTON, DICKINSON AND COMPANY
CARDINAL HEALTH, INC.
F. HOFFMANN-LA ROCHE LTD.
GE HEALTHCARE (A HEALTHCARE DIVISION OF GE COMPANY)
HOLOGIC, INC.
KONINKLIJKE PHILIPS N.V. (PHILIPS HEALTHCARE)
QUEST DIAGNOSTICS INCORPORATED.
SIEMENS AKTIENGESELLSCHAFT
bioMérieux SA
KEY FINDINGS OF STUDY
By type, the diagnostic tests was the highest contributor to the market in 2020.
By end user, the hospitals & clinics segment dominated the market in 2020 and is expected to continue this trend during the forecast period.
On the basis of womens health diagnostics market analysis, North America garnered the largest revenue share in 2020; however, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.
Get Customized Report @ https://www.alliedmarketresearch.com/request-for-customization/4521
